The store will not work correctly when cookies are disabled.
4-[3-(4-Methylphenyl)-4-ethyl-4-methyl-5-oxo-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
ID: ALA1085704
PubChem CID: 46889902
Max Phase: Preclinical
Molecular Formula: C21H18F3N3OS
Molecular Weight: 417.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C)cc1
Standard InChI: InChI=1S/C21H18F3N3OS/c1-4-20(3)18(28)26(19(29)27(20)15-8-5-13(2)6-9-15)16-10-7-14(12-25)17(11-16)21(22,23)24/h5-11H,4H2,1-3H3
Standard InChI Key: BJTOQXDHWPSSDG-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
7.2444 -7.7916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2432 -8.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9581 -9.0319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6745 -8.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6716 -7.7880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9563 -7.3789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5287 -7.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8141 -6.9612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5284 -9.0309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8143 -8.6179 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.5278 -9.8559 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.3156 -8.2339 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.3422 -9.0955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3495 -9.9205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1363 -10.1685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6154 -9.4968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1245 -8.8337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6864 -10.4113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3724 -8.0469 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.1292 -10.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8458 -10.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4393 -9.4878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8592 -10.2002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6842 -10.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0903 -9.4716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6653 -8.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8417 -8.7705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9152 -9.4617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4111 -11.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 8 3 0
1 7 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
4 13 1 0
14 18 2 0
2 9 1 0
17 19 2 0
4 5 1 0
15 20 1 0
9 10 1 0
15 21 1 0
16 22 1 0
2 3 1 0
9 11 1 0
22 23 2 0
5 6 2 0
23 24 1 0
9 12 1 0
24 25 2 0
13 14 1 0
25 26 1 0
6 1 1 0
26 27 2 0
27 22 1 0
1 2 2 0
25 28 1 0
3 4 2 0
20 29 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 417.46 | Molecular Weight (Monoisotopic): 417.1123 | AlogP: 5.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 47.34 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.97 | CX LogD: 5.97 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.64 | Np Likeness Score: -1.19 |
References
1. Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J.. (2010) Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)., 53 (7): [PMID:20218717] [10.1021/jm901488g] |